4th International Conference on Biomolecular Engineering

ICBE brings together researchers who are using quantitative approaches to advance the understanding and application of molecular biology. These scientists, engineers, and professionals are contributing to the development of analytical, diagnostic, and therapeutic strategies that are directly relevant to public health. The conference, co-chaired by Ali Khademhosseini (Harvard University) and Kristala Prather (MIT) will stimulate efforts to integrate these approaches across the scales of biological complexity in a single-track Gordon-style conference format that includes hotel accommodations and most meals. The meeting will be held January 13-16, 2013 at the Pier Sixty Six in Fort Lauderdale,FL.
+ show speakers and program
George Church is Professor of Genetics at Harvard Medical School and Director of NIH-CEGS and DOE-GTL Genomics Centers. He has pioneered technology innovations early in the development of key fields in chemistry and biomedicine. As part of technology transfer to the commercial sector he has founded 12 companies and served as scientific advisor for several others. In 1984, he developed the first direct genomic sequencing method, which resulted in the first commercial genome sequence (the human pathogen, H. pylori).






James Collins is a Professor of Biomedical Engineering at Boston University and a Howard Hughes Medical Institute Investigator. A former Rhodes Scholar, he has been the recipient of many scientific honours including, in 2003, becoming the first bioengineer to receive a MacArthur Foundation "genius award". Dr. Collins’ research group works in synthetic biology and systems biology, with a particular focus on network biology approaches to antibiotic action and bacterial defense mechanisms.

Virginia Cornish is a Professor of Chemistry at Columbia University. Her laboratory brings together modern methods in synthetic chemistry and DNA technology to co-opt cells to carry out new functions. Her research has been recognized by numerous awards including the American Chemical Society Pfizer Award in Enzyme Chemistry, the Paul Dowd Lectureship, a Sloan Foundation Fellowship, a Beckman Young Investigator Award, and a NSF Career Award.

Nicholas A. Peppas, is the Fletcher Pratt Chaired Professor of Chemical Engineering, Biomedical Engineering and Pharmacy at the University of Texas at Austin. He is a world leader in biomaterials, controlled drug delivery, biomaterials and bionanotechnology. He received a Dipl. Eng. from NTU Athens (1971) and a Sc. D. from MIT (1973). Peppas is an active researcher in the fields of bionanotechnology, remote sensing, molecular recognition processes, controlled drug delivery, biomedical engineering, biomaterials, molecular modeling of protein structures in contact with biomaterials and tissues, and modeling of biomedical devices.

Invited Speakers

Biomolecular Engineering for Cell and Tissue Engineering
David Schaffer (University of California, Berkeley)

Experimental & Computational Tools for Engineering Biomolecules
Ravi Radhakrishnan (University of Pennsylvania)
Charlie Boone (University of Toronto)

Interface of Bionanotechnology and Biomolecules
Yi Tang (University of California, Los Angeles)

Metabolic Pathway Engineering
Hal Alper (University of Texas)
Jens Nielsen (Chalmers University of Technology)

Protein Engineering
Matt DeLisa (Cornell University)

Synthetic Biology
Pam Silver (Harvard University)
Chris Voigt (Massachusetts Institute of Technology)

Biophysical and Microscale Analyses of Molecular and Cellular Function
Celeste Nelson (Princeton University)

13 Jan - 16 Jan 2013

Fort Lauderdale
United States of America
meeting website